Martin Jädersten

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 813 citations · Full text

Medicine, Genetics, Hematology +16

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 636 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

<i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

Martin Jädersten, Leonie Saft, Alexander Smith et al. · Journal of Clinical Oncology · 2011 · 460 citations · Full text

Medicine, Hematology, Oncology +17

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Luca Malcovati, Mohsen Karimi, Elli Papaemmanuil et al. · Blood · 2015 · 428 citations

Life Sciences, Genetics, Molecular Genetics +11

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Martin Jädersten, Luca Malcovati, Ingunn Dybedal et al. · Journal of Clinical Oncology · 2008 · 297 citations · Full text

Medicine, Hematology, Chemotherapy +13